Rafferty Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77M | Buy |
|
|||||
|
2025
Q1 | $4.36M | Sell |
|
|||||
|
2024
Q4 | $4.26M | Sell |
|
|||||
|
2024
Q3 | $8.34M | Buy |
|
|||||
|
2024
Q2 | $7.68M | Sell |
|
|||||
|
2024
Q1 | $9.5M | Sell |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $8.33M | Buy |
|
|||||
|
2023
Q2 | $6.24M | Sell |
|
|||||
|
2023
Q1 | $4.93M | Sell |
|
|||||
|
2022
Q4 | $4.88M | Buy |
|
|||||
|
2022
Q3 | $3.64M | Buy |
|
|||||
|
2022
Q2 | $2.18M | Sell |
|
|||||
|
2022
Q1 | $3.99M | Buy |
|
|||||
|
2021
Q4 | $2.27M | Buy |
|
|||||
|
2021
Q3 | $1.21M | Buy |
|
|||||
|
2021
Q2 | $1.52M | Sell |
|
|||||
|
2021
Q1 | $2M | Buy |
|
|||||
|
2020
Q4 | $258K | Sell |
|
|||||
|
2020
Q3 | $561K | Buy |
|
|||||
|
2020
Q2 | $320K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $693K | Sell |
|
|||||
|
2019
Q3 | $925K | Buy |
|